Primary Immunodeficiency Market Analysis, Size, Share, and Forecast 2031
The Primary Immunodeficiency Market in 2023 is US$ 8.32 billion, and is expected to reach US$ 14.01 billion by 2031 at a CAGR of 6.70%.
The Primary Immunodeficiency Market in 2023 is US$ 8.32 billion, and is expected to reach US$ 14.01 billion by 2031 at a CAGR of 6.70%.